MetaCap

Pliant Therapeutics Insider Trades

NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5951-0.0249 (-4.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
4 · $163.62K
Shares bought / sold
0 / 127.83K
Net activity
Net selling $163,620

Pliant Therapeutics insider activity

Over the last 12 months, Pliant Therapeutics insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $163,620 worth of stock, for net insider selling of $163,620. The largest seller was Coulie Bernard, with $114,400 in reported sales.

The most recent filing shows Coulie Bernard (President and CEO) selling 89,375 shares at $1.28 on Jan 20, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PLRX insider transactions

Pliant Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jan 20, 2026Kuo MinnieChief Operating OfficerSale6,917$8.85KForm 4
Jan 20, 2026Cheung LilyChief Human Resource OfficerSale7,534$9.64KForm 4
Jan 20, 2026Cummings Keith LamontChief Financial OfficerSale24,002$30.72KForm 4
Jan 20, 2026Coulie BernardPresident and CEOSale89,375$114.40KForm 4
Jan 23, 2025Lefebvre EricChief Medical OfficerAward45,650—Form 4
Jan 23, 2025Ouimette MikeGeneral Counsel & Corp. Sec'yAward35,000—Form 4
Jan 23, 2025Hull HansChief Business OfficerAward40,150—Form 4
Jan 23, 2025Coulie BernardPresident and CEOAward162,500—Form 4
Jan 23, 2025Cummings Keith LamontChief Financial OfficerAward56,650—Form 4
Jan 23, 2025Cheung LilyChief Human Resource OfficerAward25,875—Form 4
Jan 17, 2025Lefebvre EricChief Medical OfficerSale18,478$206.97KForm 4
Jan 17, 2025Hull HansChief Business OfficerSale15,936$178.50KForm 4
Jan 17, 2025Cummings Keith LamontChief Financial OfficerSale20,148$225.68KForm 4
Jan 17, 2025Coulie BernardPresident and CEOSale52,419$587.15KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related